A Possible Role of Acrolein in Diabetic Retinopathy: Involvement of a VEGF/TGFβ Signaling Pathway of the Retinal Pigment Epithelium in Hyperglycemia

REFERENCES

• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Chen M, Zhang Y et al. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem Res Toxicol 2007;20:986–990.
   PubMed Web of Science ®Google Scholar
• Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 1999;9:109–113.
   PubMed Web of Science ®Google Scholar
• Pan J, Keffer J, Emami A et al. Acrolein-derived DNA adduct formation in human colon cancer cells: its role in apoptosis induction by docosahexaenoic acid. Chem Res Toxicol 2009;22:798–806.
   PubMed Web of Science ®Google Scholar
• Bazan NG. Survival signaling in retinal pigment epithelial cells in response to oxidative stress: significance in retinal degenerations. Adv Exp Med Biol 2006;572:531–540.
   PubMed Web of Science ®Google Scholar
• Medina-Navarro R, Duran-Reyes G, Diaz-Flores M et al. Glucose-stimulated acrolein production from unsaturated fatty acids. Hum Exp Toxicol 2004;23:101–105.
   Google Scholar
• O’Brien PJ, Siraki AG, Shangari N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 2005;35:609–662.
   PubMed Web of Science ®Google Scholar
• Uchida K, Kanematsu M, Morimitsu Y et al. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem 1998;273:16058–16066.
   PubMed Web of Science ®Google Scholar
• Chung FL, Young R, Hecht SS. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res 1984;44:990–995.
   PubMed Web of Science ®Google Scholar
• LoPachin RM, Barber DS, Gavin T. Molecular mechanisms of the conjugated alpha,β-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol Sci 2008;104:235–249.
   PubMed Web of Science ®Google Scholar
• Komeima K, Rogers BS, Lu L et al. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci USA 2006;103:11300–11305.
   PubMed Web of Science ®Google Scholar
• Yong PH, Zong H, Medina RJ et al. Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Muller glia dysfunction and death in diabetic retinopathy. Mol Vis 2010;16:2524–2538.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lai Y, McCance DR et al. Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy. Diabetologia 2008;51:1723–1730.
   PubMed Web of Science ®Google Scholar
• Vidro-Kotchan E. The reactive aldehyde, acrolein, and factors associated with proliferative retinopathy. Department of Biology, University of Texas at San Antonio, San Antonio, Texas, 2010.
   Google Scholar
• Nicoletti R, Venza I, Ceci G et al. Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina. Br J Ophthalmol 2003;87:1038–1042.
   Google Scholar
• Vogt RR, Unda R, Yeh LC et al. Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells. J Cell Biochem 2006;98:1196–1202.
   PubMed Web of Science ®Google Scholar
• Dawson DW, Volpert OV, Gillis P et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245–248.
   PubMed Web of Science ®Google Scholar
• Pfeffer BA, Flanders KC, Guérin CJ et al. Transforming growth factor β 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res 1994;59:323–333.
   PubMed Web of Science ®Google Scholar
• Simó R, Villarroel M, Corraliza L et al. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier–implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010;2010:190724.
   PubMedGoogle Scholar
• Stevens JF, Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 2008;52:7–25.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994;43:836–841.
   PubMed Web of Science ®Google Scholar
• Ellis EA, Grant MB, Murray FT et al. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 1998;24:111–120.
   PubMed Web of Science ®Google Scholar
• Suzuki D, Miyata T. Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern Med 1999;38:309–314.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Edelstein D, Du XL et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787–790.
   PubMed Web of Science ®Google Scholar
• Curtis TM, Hamilton R, Yong PH et al. Muller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 2011;54:690–698.
   PubMed Web of Science ®Google Scholar
• Tsukahara H, Sekine K, Uchiyama M et al. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr Res 2003;54:419–424.
   PubMedGoogle Scholar
• Daimon M, Sugiyama K, Kameda W et al. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr J 2003;50:61–67.
   PubMed Web of Science ®Google Scholar
• Noiri E, Yamada S, Nakao A et al. Serum protein acrolein adducts: utility in detecting oxidant stress in hemodialysis patients and reversal using a vitamin E-bonded hemodialyzer. Free Radic Biol Med 2002;33:1651–1656.
   Google Scholar
• Vidro-Kotchan E, Yendluri BB, Le-Thai T et al. NBHA reduces acrolein-induced changes in ARPE-19 cells: possible involvement of TGFβ. Curr Eye Res 2011;36:370–378.
   PubMed Web of Science ®Google Scholar
• Heimsath EG Jr, Unda R, Vidro E et al. ARPE-19 cell growth and cell functions in euglycemic culture media. Curr Eye Res 2006;31:1073–1080.
   PubMed Web of Science ®Google Scholar
• Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 1986;83:2496-2500.
   PubMed Web of Science ®Google Scholar
• Grigsby JG, Parvathaneni K, Almanza MA et al. Effects of tamoxifen versus raloxifene on retinal capillary endothelial cell proliferation. J Ocul Pharmacol Ther 2011;27:225–233.
   Google Scholar
• Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression. Mol Pharmacol 2006;69:597–607.
   PubMed Web of Science ®Google Scholar
• Diaz FJ, Wigglesworth K, Eppig JJ. Oocytes determine cumulus cell lineage in mouse ovarian follicles. J Cell Sci 2007;120:1330–1340.
   PubMedGoogle Scholar
• Inman GJ, Nicolás FJ, Callahan JF et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002;62:65–74.
   PubMed Web of Science ®Google Scholar
• Laping NJ, Grygielko E, Mathur A et al. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol Pharmacol 2002;62:58–64.
   PubMed Web of Science ®Google Scholar
• Woodruff TJ, Wells EM, Holt EW et al. Estimating risk from ambient concentrations of acrolein across the United States. Environ Health Perspect 2007;115:410–415.
   PubMed Web of Science ®Google Scholar
• Batista CK, Brito GA, Souza ML et al. A model of hemorrhagic cystitis induced with acrolein in mice. Braz J Med Biol Res 2006;39:1475–1481.
   PubMed Web of Science ®Google Scholar
• Park YS, Taniguchi N. Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Ann N Y Acad Sci 2008;1126:185–189.
   PubMed Web of Science ®Google Scholar
• Saiki R, Nishimura K, Ishii I et al. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 2009;40:3356–3361.
   PubMed Web of Science ®Google Scholar
• Tomitori H, Usui T, Saeki N et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005;36:2609–2613.
   PubMed Web of Science ®Google Scholar
• Joshi-Barve S, Amancherla K, Patil M et al. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. Free Radic Biol Med 2009;47:47–54.
   PubMedGoogle Scholar
• Sakata K, Kashiwagi K, Sharmin S et al. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 2003;305:143–149.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s disease. Nucleic Acids Res 2007;35:7497–7504.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer’s disease. J Neurosci Res 2007;85:3036–3040.
   PubMed Web of Science ®Google Scholar
• Williams TI, Lynn BC, Markesbery WR et al. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer’s disease. Neurobiol Aging 2006;27:1094–1099.
   PubMed Web of Science ®Google Scholar
• Jia L, Liu Z, Sun L et al. Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by ®-alpha-lipoic acid. Invest Ophthalmol Vis Sci 2007;48:339–348.
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun L, Zhu L et al. Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem 2007;103:2690–2700.
   PubMed Web of Science ®Google Scholar
• Sheu SJ, Liu NC, Chen JL. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther 2010;26:231–236.
   PubMed Web of Science ®Google Scholar
• Feng Z, Liu Z, Li X et al. α-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. J Nutr Biochem 2010;21:1222–1231.
   Google Scholar
• Shen JK, Dong A, Hackett SF et al. Oxidative damage in age-related macular degeneration. Histol Histopathol 2007;22:1301–1308.
   PubMed Web of Science ®Google Scholar
• Wood PL, Khan MA, Moskal JR. The concept of “aldehyde load” in neurodegenerative mechanisms: cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3-acetamidopropanal and 4-aminobutanal in a retinal ganglion cell line. Brain Res 2007;1145:150–156.
   PubMed Web of Science ®Google Scholar
• Wood PL, Khan MA, Kulow SR et al. Neurotoxicity of reactive aldehydes: the concept of “aldehyde load” as demonstrated by neuroprotection with hydroxylamines. Brain Res 2006;1095:190–199.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Tomitori H, Machi Y et al. Acrolein toxicity: comparison with reactive oxygen species. Biochem Biophys Res Commun 2009;378:313–318.
   PubMed Web of Science ®Google Scholar
• Du XL, Edelstein D, Rossetti L et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000;97:12222–12226.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–820.
   PubMed Web of Science ®Google Scholar
• Callahan JF, Burgess JL, Fornwald JA et al. Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5). J Med Chem 2002;45:999–1001.
   PubMed Web of Science ®Google Scholar
• Inoue Y, Canaff L, Hendy GN et al. Role of Smad3, acting independently of transforming growth factor-β, in the early induction of Wnt-β-catenin signaling by parathyroid hormone in mouse osteoblastic cells. J Cell Biochem 2009;108:285–294.
   Google Scholar
• Carlsson LM, Jacobson P, Walley A et al. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun 2009;382:309–314.
   Google Scholar
• Esser P, Heimann K, Bartz-schmidt KU et al. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-β-induced RPE cell apoptosis. Exp Eye Res 1997;65:365–378.
   PubMedGoogle Scholar
• Kishi H, Kuroda E, Mishima HK et al. Role of TGF-β in the retinoic acid-induced inhibition of proliferation and melanin synthesis in chick retinal pigment epithelial cells in vitro. Cell Biol Int 2001;25:1125–1129.
   Google Scholar
• Mitsuhiro MR, Eguchi S, Yamashita H. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-β superfamily. Acta Ophthalmol Scand 2003;81:630–638.
   PubMedGoogle Scholar
• Lee SC, Seong GJ, Kim SH et al. Synthesized TGF-β s in RPE regulates cellular proliferation. Korean J Ophthalmol 1999;13:16–24.
   PubMedGoogle Scholar
• Parent RA, Paust DE, Schrimpf MK et al. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identification of urinary and fecal metabolites. Toxicol Sci 1998;43:110–120.
   Google Scholar
• Palma S, Cornetta T, Padua L et al. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res 2007;633:1–12.
   PubMed Web of Science ®Google Scholar
• Crabb DW, Matsumoto M, Chang D et al. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004;63:49–63.
   PubMed Web of Science ®Google Scholar
• Choudhary S, Xiao T, Srivastava S et al. Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol Appl Pharmacol 2005;204:122–134.
   PubMed Web of Science ®Google Scholar
• Rees JN, Florang VR, Anderson DG et al. Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate. Chem Res Toxicol 2007;20:1536–1542.
   Google Scholar
• Traverso N, Menini S, Odetti P et al. Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic Biol Med 2002;32:350–359.
   PubMed Web of Science ®Google Scholar
• Betts BS, Parvathaneni K, Yendluri BB et al. Ginsenoside-Rb-1 induces ARPE-19 proliferation and reduces VEGF release. ISRN Ophthalmol 2011;2011:6.
   Google Scholar
• Sigma-Aldrich. Material Safety Data Sheets. 2012. Available at: http://www.sigmaaldrich.com.
   Google Scholar